How TytoCare CEO Dedi Gilad grew TytoCare to $82.9M revenue with a 267 person team in 2023.

TytoCare is revolutionizing primary care by empowering consumers with the tools they need to take control of their health. With a focus on convenience and accessibility, TytoCare seamlessly connects people with clinicians to offer top-tier home examination and diagnosis solutions. The company's mission is centrally focused on providing consumers and clinicians with a seamless, cost-effective, and high-quality telehealth experience that includes comprehensive medical exams from the comfort of their homes. TytoCare offers two innovative telehealth products: TytoHome and TytoPro. TytoHome serves as a remote examination tool and telehealth platform that enables consumers to connect with clinicians for an extensive medical examination covering areas such as the ears, nose, throat, lungs, heart, and temperature measurement — accessible anytime and anywhere. On the other hand, TytoPro is designed for medical professionals, acting as a professional examination tool and telehealth platform that facilitates the sharing of remote exam data among practitioners. This can be for the purposes of specialist consultations, obtaining second opinions, or even using it in-office to enhance patient communication regarding diagnoses and recommended treatments. Founded in 2012 by Dedi Gilad, Ofer Tzadik, and a team of industry experts, TytoCare started with a clear vision to make healthcare more accessible to consumers. Since its inception, the company has successfully secured over $18 million in funding from a diverse group of investors, including notable names such as Walgreens, Cambia Health Solutions, OrbiMed, Fosun Pharma, LionBird, and Teuza. This funding has helped propel TytoCare's mission forward, ensuring the continued development of their technology and expansion of their services. For more information on how TytoCare is transforming the healthcare landscape, visit www.tytocare.com.

Last updated Dec 1, 2023